Axonics Modulation Technologies Inc. (AXNX) Misses Q4 EPS by 18c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. LITE
5. CL
6. LYB
7. TFII
8. NVT
9. SPY
10. AAPL

Go back to Axonics Modulation Technologies Inc. (AXNX) Misses Q4 EPS by 18c, Revenues Beat

Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update

March 5, 2019 4:00 PM EST

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (SNM) devicesfor the treatment ofurinary and bowel dysfunction, reported today financial results for the fourth quarter and year endedDecember31, 2018, and provided an update on operational initiatives.

Recent Business Highlights

In Q4, commercial sales of the... More